Vanberra Signal

Pro-Mapp

Curated by Signal

Suite of intelligent applications for patient care & research

Overview

Pro-Mapp, a spin-out company from Oxford University provides intelligent applications of patient-reported outcome measures to enhance patient care and to boost clinical research. Its products include Clinical Pathway Application called Pro-Path that provides evidence and outcome-based decisions based on clinical and surgical pathways; subscription-based service PRO-QUOL for a clinician to use authenticated survey tools; Pro-Ssafe for collaboration between patients, providers, manufacturers and regulatory bodies and a managed service or a software installation called PRO-TRIALS. The company is also in plans to launch other products like pathway products for clinicians to focus on their patients and on-demand Patient Reported Outcome tool called Fr3proms.

Key facts

Founded
2016

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of services and products for integrated drug discovery

    Health TechnologyNottingham, United Kingdom
  • Developer of AI-based computational tools to discover therapeutics

    Health TechnologyCambridge, United Kingdom
  • Provider of assistive devices for the disabled

    Health TechnologyLeeds, United Kingdom

About Pro-Mapp

What does Pro-Mapp do?

Pro-Mapp, a spin-out company from Oxford University provides intelligent applications of patient-reported outcome measures to enhance patient care and to boost clinical research.

Where is Pro-Mapp headquartered?

Pro-Mapp is headquartered in Oxford, United Kingdom.

When was Pro-Mapp founded?

Pro-Mapp was founded in 2016.

Which sector is Pro-Mapp in?

Pro-Mapp operates in Health Technology.

Who are Pro-Mapp's competitors?

Companies similar to Pro-Mapp include Sygnature Discovery, Ensocell, and Comma Care.